Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,728 | 290 | 95.9% |
| Education | $199.90 | 2 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,148 | 128 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $392.79 | 23 | $0 (2023) |
| Janssen Biotech, Inc. | $388.16 | 24 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $361.55 | 19 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $205.94 | 12 | $0 (2023) |
| QOL Medical, LLC | $195.39 | 9 | $0 (2023) |
| Gilead Sciences, Inc. | $159.19 | 13 | $0 (2021) |
| Celgene Corporation | $130.02 | 8 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $122.72 | 8 | $0 (2023) |
| Merck Sharp & Dohme LLC | $101.79 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $113.92 | 5 | ABBVIE INC. ($80.66) |
| 2023 | $1,109 | 66 | ABBVIE INC. ($428.48) |
| 2022 | $1,800 | 97 | ABBVIE INC. ($841.42) |
| 2021 | $1,905 | 124 | AbbVie Inc. ($797.29) |
All Payment Transactions
292 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/01/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: IMMUNOLOGY | ||||||
| 01/05/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $33.26 | General |
| 01/04/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/27/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Gastroenterology | ||||||
| 12/05/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/01/2023 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/30/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/29/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Immunology | ||||||
| 11/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: CNS | ||||||
| 11/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/03/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: VIROLOGY | ||||||
| 11/02/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/27/2023 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Immunology | ||||||
| 10/25/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/13/2023 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: GI COLON PREP | ||||||
| 10/12/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $33.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/12/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $33.61 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: IMMUNOLOGY | ||||||
| 10/06/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 139 | 161 | $26,124 | $8,539 |
| 2022 | 6 | 213 | 265 | $37,898 | $13,285 |
| 2021 | 7 | 237 | 323 | $46,564 | $17,765 |
| 2020 | 4 | 161 | 224 | $39,912 | $13,351 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 112 | $23,699 | $7,743 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $1,942 | $522.63 | 26.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 18 | 22 | $315.00 | $184.80 | 58.7% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 12 | 14 | $168.00 | $88.76 | 52.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 141 | $29,455 | $10,200 | 34.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 39 | $4,860 | $1,825 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 18 | $2,662 | $883.89 | 33.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 15 | 17 | $391.00 | $177.18 | 45.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 30 | 35 | $350.00 | $103.65 | 29.6% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 13 | 15 | $180.00 | $95.58 | 53.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 118 | 174 | $36,071 | $13,793 | 38.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 39 | 56 | $7,056 | $2,649 | 37.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 15 | $2,181 | $780.00 | 35.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 12 | 16 | $368.00 | $168.96 | 45.9% |
| 87324 | Detection test by immunoassay technique for clostridium difficile toxins (stool pathogen) | Office | 2021 | 13 | 13 | $338.00 | $155.74 | 46.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 14 | 15 | $210.00 | $116.55 | 55.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 26 | 34 | $340.00 | $102.00 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 96 | 147 | $28,659 | $9,399 | 32.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 48 | $6,432 | $2,203 | 34.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 16 | $3,075 | $1,118 | 36.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 13 | $1,746 | $630.73 | 36.1% |
About Cydne Evans
Cydne Evans is a Physician Assistant healthcare provider based in Provo, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2015. The National Provider Identifier (NPI) number assigned to this provider is 1750763629.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cydne Evans has received a total of $4,928 in payments from pharmaceutical and medical device companies, with $113.92 received in 2024. These payments were reported across 292 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,728).
As a Medicare-enrolled provider, Evans has provided services to 750 Medicare beneficiaries, totaling 973 services with total Medicare billing of $52,940. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Provo, UT
- Active Since 06/26/2015
- Last Updated 11/27/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1750763629
Products in Payments
- HUMIRA (Biological) $613.44
- CREON (Drug) $451.61
- RINVOQ (Biological) $385.93
- ZENPEP (Drug) $361.55
- ENTYVIO (Biological) $316.52
- STELARA (Biological) $302.90
- LINZESS (Drug) $265.54
- MAVYRET (Drug) $209.62
- SKYRIZI (Biological) $151.38
- SUCRAID (Drug) $146.60
- XIFAXAN (Drug) $146.50
- ZEPOSIA (Drug) $130.02
- OCALIVA (Drug) $122.72
- DUPIXENT (Biological) $122.53
- INJECTAFER (Drug) $100.31
- RENFLEXIS (Drug) $94.81
- IBSRELA (Drug) $86.41
- REMICADE (Biological) $85.26
- XELJANZ (Drug) $82.92
- VIBERZI (Drug) $70.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Provo
John Whitehead, Pa, PA
Physician Assistant — Payments: $22,797
Bryce Hancock, Pa, PA
Physician Assistant — Payments: $12,872
Shauna Whatcott-Sclafani, Pa, PA
Physician Assistant — Payments: $7,597
Elizabeth Mahoney, Pa, PA
Physician Assistant — Payments: $5,515
Daniel Jones, Pa, PA
Physician Assistant — Payments: $5,444
Cory Miller, Pa, PA
Physician Assistant — Payments: $5,196